Skip to main content
logo
BlossomHill Therapeutics, Inc. (BLSM)
NASDAQ: BLSM · Real-Time Price · USD
23.12
-2.13 (-8.44%)
Sep 23, 2026, 10:58 AM EDT - Market open

BlossomHill Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
95.38136.68100.15
Cash & Short-Term Investments
95.38136.68100.15
Cash Growth
-36.48%-
Prepaid Expenses
5.592.144.03
Total Current Assets
100.97138.83104.17
Property, Plant & Equipment
20.6921.651.59
Other Long-Term Assets
2.482.51.02
Total Assets
124.13162.97106.78

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
3.932.310.85
Accrued Expenses
12.7313.165.4
Current Portion of Leases
1.150.010.53
Total Current Liabilities
18.6215.486.77
Long-Term Leases
22.2222.39-
Total Liabilities
42.0937.876.77

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
000
Additional Paid-In Capital
5.013.31.59
Retained Earnings
-179.8-135.03-74.47
Total Common Equity
-174.78-131.73-72.88
Shareholders' Equity
82.04125.1100
Total Liabilities & Equity
124.13162.97106.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
23.3722.40.53
Net Cash (Debt)
72.01114.2899.62
Net Cash Growth
-14.72%-
Net Cash Per Share
28.0846.8743.50
Filing Date Shares Outstanding
2.772.552.29
Total Common Shares Outstanding
2.772.552.29
Working Capital
82.35123.3597.4
Book Value Per Share
-63.15-51.68-31.82
Tangible Book Value
-174.78-131.73-72.88
Tangible Book Value Per Share
-63.15-51.68-31.82
Machinery
-2.621.87
Leasehold Improvements
-0.270.1
SEC Filings: 10-K · 10-Q